Pattern of tumor regression after neoadjuvant chemoimmunotherapy for esophageal squamous cell carcinoma

BACKGROUND: Immune checkpoint inhibitors have been increasingly applied for esophageal cancer. The aims of this study were to evaluate the pattern of tumor regression after neoadjuvant chemoimmunotherapy. METHODS: From January 2020 to December 2021, 138 patients with esophageal squamous cell carcino...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bin, Wang, Yichen, Yu, Hui, Chen, Haiqing, Sun, Yihua, Hu, Hong, Zhang, Yawei, Xiang, Jiaqing, Li, Yuan, Chen, Haiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636475/
https://www.ncbi.nlm.nih.gov/pubmed/37969295
http://dx.doi.org/10.21037/jtd-23-882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636475/
https://www.ncbi.nlm.nih.gov/pubmed/37969295
http://dx.doi.org/10.21037/jtd-23-882

Ejemplares similares